Screener
Veracyte VCYT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| General and administrative | 23,680 | 33,808 |
| Intangible asset amortization - operating expenses | 579 | 622 |
| Total operating expenses | 78,513 | 76,604 |
| Income from operations | 22,646 | 2,904 |
| Other income, net | 7,328 | 4,524 |
| Income before income taxes | 29,974 | 7,428 |
| Income tax provision | 1,267 | 381 |
| Net income | $28,707 | $7,047 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's operating income?
- Veracyte (VCYT) reported operating income of $22.65M in Q1 2026.
- How has Veracyte's operating income changed year-over-year?
- Veracyte's operating income increased by 679.8% year-over-year, from $2.9M to $22.65M.
- What is the long-term trend for Veracyte's operating income?
- Over 4 years (2021 to 2025), Veracyte's operating income has grown at a -8.4% compound annual growth rate (CAGR), from -$81.9M to $57.78M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Veracyte's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude